Education
About Us
Working with TipRanks
Follow Us
United Therapeutics Corp. (UTHR)
NASDAQ:UTHR
UTHR Analyst Ratings
Moderate Buy
9 Buy
4 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UTHR Stock 12 Month Forecast
Average Price Target
$546.00
▲(1.84% Upside)
| Highest Price Target$705.00 | Average Price Target$546.00 | Lowest Price Target$35.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TD Cowen
$545
Buy
1.66%
Upside
Reiterated
03/12/26
Oppenheimer
$600→$650
Buy
21.24%
Upside
Reiterated
03/12/26
UBS
$655→$705
Buy
31.50%
Upside
Assigned
03/05/26
Argus Research
$560
Buy
4.45%
Upside
Assigned
03/03/26
Wells Fargo
$466
Hold
-13.08%
Downside
Reiterated
03/03/26
H.C. Wainwright
$600→$35
Buy
-93.47%
Downside
Reiterated
03/02/26
Bank of America Securities
$569
Hold
6.13%
Upside
Reiterated
03/02/26
Jefferies
$640→$668
Buy
24.60%
Upside
Reiterated
03/02/26
Leerink Partners
$600→$615
Buy
14.71%
Upside
Reiterated
03/02/26
Morgan Stanley
$447→$471
Hold
-12.15%
Downside
Reiterated
02/26/26
BTIG
―
Hold
―
Reiterated
02/25/26
RBC Capital
$587→$643
Buy
19.94%
Upside
Reiterated
02/25/26
J.P. Morgan
$345→$450
Buy
-16.06%
Downside
Reiterated
09/09/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TD Cowen
$545
Buy
1.66%
Upside
Reiterated
03/12/26
Oppenheimer
$600→$650
Buy
21.24%
Upside
Reiterated
03/12/26
UBS
$655→$705
Buy
31.50%
Upside
Assigned
03/05/26
Argus Research
$560
Buy
4.45%
Upside
Assigned
03/03/26
Wells Fargo
$466
Hold
-13.08%
Downside
Reiterated
03/03/26
H.C. Wainwright
$600→$35
Buy
-93.47%
Downside
Reiterated
03/02/26
Bank of America Securities
$569
Hold
6.13%
Upside
Reiterated
03/02/26
Jefferies
$640→$668
Buy
24.60%
Upside
Reiterated
03/02/26
Leerink Partners
$600→$615
Buy
14.71%
Upside
Reiterated
03/02/26
Morgan Stanley
$447→$471
Hold
-12.15%
Downside
Reiterated
02/26/26
BTIG
―
Hold
―
Reiterated
02/25/26
RBC Capital
$587→$643
Buy
19.94%
Upside
Reiterated
02/25/26
J.P. Morgan
$345→$450
Buy
-16.06%
Downside
Reiterated
09/09/25
Best Analysts Covering United Therapeutics
3 Months
xxx
Success Rate
15/17 ratings generated profit
Average Return
+15.95%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 88.24% of your transactions generating a profit, with an average return of +15.95% per trade.
1 Year
Success Rate
12/12 ratings generated profit
Average Return
+33.53%
reiterated a buy rating 15 days ago
Copying Roger Song's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.53% per trade.
2 Years
xxx
Success Rate
17/17 ratings generated profit
Average Return
+70.47%
reiterated a xxx
rating 15 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +70.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UTHR Analyst Recommendation Trends
Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
48
23
18
84
104
Hold
11
7
3
7
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
59
30
21
91
112
Each month's total comprises the sum of three months' worth of ratings.
UTHR Financial Forecast
UTHR Stock Forecast FAQ
What is UTHR’s average 12-month price target, according to analysts?
Based on analyst ratings, United Therapeutics Corp.’s 12-month average price target is 546.00.
What is UTHR’s upside potential, based on the analysts’ average price target?
United Therapeutics Corp. has 1.84% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is UTHR a Buy, Sell or Hold?
United Therapeutics Corp. has a consensus rating of Moderate Buy which is based on 9 buy ratings, 4 hold ratings and 0 sell ratings.
What is United Therapeutics Corp.’s price target?
The average price target for United Therapeutics Corp. is 546.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $705.00 ,the lowest forecast is $35.00. The average price target represents 1.84% Increase from the current price of $536.12.
The highest analyst price target is $705.00 ,the lowest forecast is $35.00. The average price target represents 1.84% Increase from the current price of $536.12.
What do analysts say about United Therapeutics Corp.?
United Therapeutics Corp.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of UTHR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.